Viewing Study NCT03989232


Ignite Creation Date: 2025-12-24 @ 9:40 PM
Ignite Modification Date: 2026-02-01 @ 4:13 PM
Study NCT ID: NCT03989232
Status: COMPLETED
Last Update Posted: 2023-02-13
First Post: 2019-06-14
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetes
Sponsor: Novo Nordisk A/S
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes Mellitus, Type 2 View
Keywords: